|
Powered by Cell Signaling Technology |
Site Information |
---|
AGEYGAVtYRKSkRG SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 25544600 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Putative in vivo kinases: | |
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on PINK1: | |
Effects of modification on biological processes: |
Disease / Diagnostics Relevance | |
---|---|
Relevant diseases: |
References | |
---|---|
Ponia SS, et al. (2021) Mitophagy antagonism by ZIKV reveals Ajuba as a regulator of PINK1 signaling, PKR-dependent inflammation, and viral invasion of tissues. Cell Rep 37, 109888
34706234 Curated Info |
|
Geldenhuys WJ, Abdelmagid SM, Gallegos PJ, Safadi FF (2014) Parkinson's disease biomarker: a patent evaluation of WO2013153386. Expert Opin Ther Pat 24, 947-51
24962176 Curated Info |
|
Hertz NT, et al. (2013) A Neo-Substrate that Amplifies Catalytic Activity of Parkinson's-Disease-Related Kinase PINK1. Cell 154, 737-47
23953109 Curated Info |
|
Kondapalli C, et al. (2012) PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol 2, 120080
22724072 Curated Info |